Trial Profile
Study of eculizumab in patients with paroxysmal nocturnal hemoglobinuria.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Sep 2015
Price :
$35
*
At a glance
- Drugs Eculizumab (Primary)
- Indications Paroxysmal nocturnal haemoglobinuria
- Focus Therapeutic Use
- 24 Sep 2015 New trial record